AR050718A1 - CO-CRYSTALS BETWEEN POLYETHYLENE GLYCOLSY 5-PHENYLPIRAZOLIL-1-BENCENSULPHONAMIDS. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS. - Google Patents

CO-CRYSTALS BETWEEN POLYETHYLENE GLYCOLSY 5-PHENYLPIRAZOLIL-1-BENCENSULPHONAMIDS. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.

Info

Publication number
AR050718A1
AR050718A1 ARP050103631A ARP050103631A AR050718A1 AR 050718 A1 AR050718 A1 AR 050718A1 AR P050103631 A ARP050103631 A AR P050103631A AR P050103631 A ARP050103631 A AR P050103631A AR 050718 A1 AR050718 A1 AR 050718A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
obtaining
processes
phenylpirazolil
glycolsy
Prior art date
Application number
ARP050103631A
Other languages
Spanish (es)
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of AR050718A1 publication Critical patent/AR050718A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procesos de obtencion y composiciones farmacéuticas que los contienen. Reivindicacion 1: Un co-cristal que comprende un compuesto de formula (1) en la que R1 se selecciona de H o alquilo C1-4; R2 y R3 se seleccionan independientemente del grupo constituido por H, halogeno, alquilo C1-4, haloalquilo C1-4, ciano, nitro, formilo, carboxilo y alcoxicarbonilo; R4 representa de uno a tres sustituyentes seleccionados independientemente del grupo constituido por H, alquilo C1-4, haloalquilo C1-4, ciano, nitro y halogeno; y un polietilenglicol.Obtaining processes and pharmaceutical compositions containing them. Claim 1: A co-crystal comprising a compound of formula (1) wherein R1 is selected from H or C1-4 alkyl; R 2 and R 3 are independently selected from the group consisting of H, halogen, C 1-4 alkyl, C 1-4 haloalkyl, cyano, nitro, formyl, carboxyl and alkoxycarbonyl; R4 represents one to three substituents independently selected from the group consisting of H, C1-4 alkyl, C1-4 haloalkyl, cyano, nitro and halogen; and a polyethylene glycol.

ARP050103631A 2004-09-01 2005-08-30 CO-CRYSTALS BETWEEN POLYETHYLENE GLYCOLSY 5-PHENYLPIRAZOLIL-1-BENCENSULPHONAMIDS. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS. AR050718A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60640404P 2004-09-01 2004-09-01

Publications (1)

Publication Number Publication Date
AR050718A1 true AR050718A1 (en) 2006-11-15

Family

ID=35207434

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103631A AR050718A1 (en) 2004-09-01 2005-08-30 CO-CRYSTALS BETWEEN POLYETHYLENE GLYCOLSY 5-PHENYLPIRAZOLIL-1-BENCENSULPHONAMIDS. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.

Country Status (3)

Country Link
AR (1) AR050718A1 (en)
TW (1) TW200621718A (en)
WO (1) WO2006024930A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
WO2004000284A1 (en) 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492411B1 (en) * 1993-11-30 2002-12-10 G. D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
TR200001872A3 (en) * 2000-06-26 2002-01-21 Fako Ilaclari A.S The new crystal form "Form I" of 4- [5- (4-Methylphenyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] benzenesulfonamide and the method for producing this product.
WO2005055983A2 (en) * 2003-12-09 2005-06-23 Medcrystalforms, Llc Method of preparation of mixed phase co-crystals with active agents

Also Published As

Publication number Publication date
WO2006024930A1 (en) 2006-03-09
TW200621718A (en) 2006-07-01

Similar Documents

Publication Publication Date Title
AR048641A1 (en) ARTH- OR HETEROARILAMIDE ORTHOSUSTITUTED COMPOUNDS USEFUL AS ANTAGO-NISTAS OF THE PROSTAGLANDINAS E2 RECEIVER; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICAME
AR047056A1 (en) DERIVATIVES OF CONDENSED PYRIMIDINS. PHARMACEUTICAL COMPOSITIONS
AR044909A1 (en) DERIVATIVES OF THIAZOLILPIPERIDINE, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND APPLICATIONS OF SUCH DERIVATIVES IN THE TREATMENT OF HYPERTRIGLICERIDEMIA, HYPERCHOLESTEROLEMIA AND DISLIPIDEMIA
CO6140033A2 (en) AMINO-IMIDAZOLES AND ITS USE AS A MEDICINAL PRODUCT TO TREAT COOGNOTIVE DISABILITY ALZHEIMER NEURODEGENERATION AND DEMENTIA DISEASE
AR062677A1 (en) DERIVATIVES OF BIARIL-SULFONAMIDE, PRODUCTION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
PE20140961A1 (en) MACROCYCLIC INHIBITORS OF SERINE PROTEASES OF HEPATITIS C
AR048778A1 (en) PIRROLIDINYL DERIVATIVES AS INHIBITORS OF 11-BETA HYDROXIESTEROID DEHYDROGENASE
CO5700754A2 (en) PIPERAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES
AR061739A1 (en) NEW NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2190396T3 (en) NEW AMINO-TRIAZOL COMPOUNDS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR033620A1 (en) ALFA-AMINO ACIDS SULFONYL COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY29393A1 (en) NEW DERIVATIVES OF AMIDAS, ACCEPTABLE PHARMACEUTICAL SALTS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS.
AR063988A1 (en) HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CO6220931A2 (en) SERINE PROTEASE INHIBITORS FOR THE TREATMENT OF HCV INFECTIONS
AR054369A1 (en) CONDENSED IMIDAZOL COMPOUNDS AND ITS USE AS ALDOSTERONE SINTASA INHIBITORS
AR073932A1 (en) ESTERES COMPOUNDS OF ACID 2- (AMINOMETILIDEN) -4,4-DIFLUORO-3- OXOBUTIRICO AND PROCEDURE FOR PREPARATION
EA201000101A1 (en) DERIVATIVES OF PYRIMIDINE 934
AR053453A1 (en) SUBSTITUTED AMINOALQUIL- AND AMIDOALQUIL-BENZOPIRANO DERIVATIVES
AR050718A1 (en) CO-CRYSTALS BETWEEN POLYETHYLENE GLYCOLSY 5-PHENYLPIRAZOLIL-1-BENCENSULPHONAMIDS. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.
AR050032A1 (en) DERIVATIVES OF BENZOIC ACID AS NON-NUCLEOSID INHIBITORS OF THE REVERSE TRANSCRIPT
DE602004024830D1 (en) THE HIV PROTEASE INHIBITING SULPHONAMIDE
UY29739A1 (en) DERIVATIVES OF AMIDAS OR PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PROCESSES OF PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND APPLICATIONS
AR054121A1 (en) PHENYL PIRIDYL PIPERAZINE COMPOUNDS, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PHARMACOLOGICAL USES AS ANTAGONIST OF HISTAMINERGIC RECEPTORS H3
UY29894A1 (en) ACID DERIVATIVES (2 - ((2S) -2-HYDROXIPROPIL) OXI) PHENYL) ACETIC AND ACID (2 - ((2S) -2-HYDROXIPROPIL) OXI) PHENYL) PROPANOIC SUBSTITUTED, PHARMACEUTICAL COMPOSITIONS OF PREPARATION AND PROCEDURE APPLICATIONS
AR052949A1 (en) METABOLITES DERIVED FROM PIRIDINE AS NK-1 ANTAGONISTS FOR EMESIS

Legal Events

Date Code Title Description
FB Suspension of granting procedure